Trial · NCT01455181
Results by group18
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 18 of 18
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Subjects Who Achieved the Primary Triple Endpoint at Week 24, Based on Investigator Prescribed Data. | NPSP558 | 75.0 | 95% Confidence Interval 53.3 to 90.2 | percentage of participants | |
| Mean Percentage Changes From Baseline in Active Vitamin D Dosages at Each Visit | NPSP558 | Week 2 | -47.08 | Standard Deviation 31.566 | percentage of change |
| Mean Percentage Changes From Baseline in Active Vitamin D Dosages at Each Visit | NPSP558 | Week 4 | -80.38 | Standard Deviation 16.688 | percentage of change |
| Mean Percentage Changes From Baseline in Active Vitamin D Dosages at Each Visit | NPSP558 | Week 8 | -96.70 | Standard Deviation 7.865 | percentage of change |
| Mean Percentage Changes From Baseline in Active Vitamin D Dosages at Each Visit | NPSP558 | Week 16 | -96.18 | Standard Deviation 11.521 | percentage of change |
| Mean Percentage Changes From Baseline in Active Vitamin D Dosages at Each Visit | NPSP558 | Week 24 | -97.92 | Standard Deviation 10.206 | percentage of change |
| Mean Percentage Changes From Baseline in Oral Calcium at Each Visit | NPSP558 | Week 2 | -8.3 | Standard Deviation 36.20 | percentage of change |
| Mean Percentage Changes From Baseline in Oral Calcium at Each Visit | NPSP558 | Week 4 | -46.4 | Standard Deviation 35.57 | percentage of change |
| Mean Percentage Changes From Baseline in Oral Calcium at Each Visit | NPSP558 | Week 8 | -71.5 | Standard Deviation 33.14 | percentage of change |
| Mean Percentage Changes From Baseline in Oral Calcium at Each Visit | NPSP558 | Week 16 | -71.7 | Standard Deviation 38.60 | percentage of change |
| Mean Percentage Changes From Baseline in Oral Calcium at Each Visit | NPSP558 | Week 24 | -76.0 | Standard Deviation 40.48 | percentage of change |
| Proportion of Patients Achieving the Primary Endpoint at Each Visit | NPSP558 | Week 2 | 20.8 | percentage of participants | |
| Proportion of Patients Achieving the Primary Endpoint at Each Visit | NPSP558 | Week 4 | 50.0 | percentage of participants | |
| Proportion of Patients Achieving the Primary Endpoint at Each Visit | NPSP558 | Week 8 | 70.8 | percentage of participants | |
| Proportion of Patients Achieving the Primary Endpoint at Each Visit | NPSP558 | Week 16 | 83.3 | percentage of participants | |
| Proportion of Patients Achieving the Primary Endpoint at Each Visit | NPSP558 | Week 24 | 83.3 | percentage of participants | |
| Mean Change From Baseline in 24-hour Urine Calcium Excretion | NPSP558 | Week 8 | -64.58 | Standard Deviation 188.42 | mg/24 hour |
| Mean Change From Baseline in 24-hour Urine Calcium Excretion | NPSP558 | Week 24 | -51.53 | Standard Deviation 183.41 | mg/24 hour |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01455181/results